The use of RBL, a fecal microbiota-based live biotherapeutic, was safe and efficacious for recurrent CDI prevention in a large cohort of adults with common comorbidities.
The Hospital and Healthsystem Association of Pennsylvania on Tuesday recognized the Pennsylvania hospitals that have achieved exemplary results preventing infections — and St. Luke’s had more ...